1832 Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $61.2M | Buy |
281,600
+180,480
| +178% | +$40M | 0.06% | 208 |
|
|
2025
Q4 | $23.1M | Buy |
101,120
+83,075
| +460% | +$18.9M | 0.02% | 286 |
|
|
2025
Q3 | $4.18M | Sell |
18,045
-2,545
| -12% | -$518K | ﹤0.01% | 390 |
|
|
2025
Q2 | $3.82M | Buy |
20,590
+12,631
| +159% | +$2.35M | ﹤0.01% | 393 |
|
|
2025
Q1 | $1.67M | Sell |
7,959
-591
| -7% | -$115K | ﹤0.01% | 506 |
|
|
2024
Q4 | $1.52M | Sell |
8,550
-127,528
| -94% | -$23.4M | ﹤0.01% | 534 |
|
|
2024
Q3 | $26.9M | Buy |
136,078
+13,202
| +11% | +$2.46M | 0.02% | 262 |
|
|
2024
Q2 | $21.1M | Sell |
122,876
-687,984
| -85% | -$114M | 0.02% | 272 |
|
|
2024
Q1 | $148M | Buy |
810,860
+752,043
| +1,279% | +$130M | 0.09% | 90 |
|
|
2023
Q4 | $9.11M | Buy |
58,817
+864
| +1% | +$126K | 0.01% | 331 |
|
|
2023
Q3 | $8.64M | Buy |
57,953
+17,827
| +44% | +$2.62M | 0.01% | 340 |
|
|
2023
Q2 | $5.41M | Sell |
40,126
-24,163
| -38% | -$3.54M | 0.01% | 381 |
|
|
2023
Q1 | $10.2M | Buy |
64,289
+40,194
| +167% | +$6.14M | 0.01% | 348 |
|
|
2022
Q4 | $3.89M | Sell |
24,095
-16,151
| -40% | -$2.48M | 0.01% | 444 |
|
|
2022
Q3 | $5.4M | Sell |
40,246
-3,294
| -8% | -$473K | 0.01% | 420 |
|
|
2022
Q2 | $6.67M | Sell |
43,540
-173,074
| -80% | -$26.4M | 0.01% | 404 |
|
|
2022
Q1 | $34.6M | Buy |
216,614
+197,993
| +1,063% | +$28.8M | 0.05% | 251 |
|
|
2021
Q4 | $2.55M | Sell |
18,621
-11,205
| -38% | -$1.32M | ﹤0.01% | 391 |
|
|
2021
Q3 | $3.28M | Buy |
29,826
+12,424
| +71% | +$1.42M | 0.01% | 417 |
|
|
2021
Q2 | $1.96M | Buy |
17,402
+9,734
| +127% | +$1.1M | ﹤0.01% | 425 |
|
|
2021
Q1 | $828K | Sell |
7,668
-435,596
| -98% | -$46.6M | ﹤0.01% | 450 |
|
|
2020
Q4 | $46.8M | Buy |
443,264
+365,982
| +474% | +$35.2M | 0.11% | 166 |
|
|
2020
Q3 | $6.76M | Sell |
77,282
-205,050
| -73% | -$19.3M | 0.02% | 292 |
|
|
2020
Q2 | $27.5M | Buy |
282,332
+197,400
| +232% | +$17.4M | 0.08% | 165 |
|
|
2020
Q1 | $6.44M | Buy |
84,932
+33,117
| +64% | +$2.82M | 0.02% | 272 |
|
|
2019
Q4 | $4.61M | Sell |
51,815
-89
| -0.2% | -$7.39K | 0.01% | 299 |
|
|
2019
Q3 | $3.88M | Buy |
51,904
+4,978
| +11% | +$341K | 0.01% | 320 |
|
|
2019
Q2 | $3.29M | Buy |
46,926
+46,726
| +23,363% | +$3.67M | 0.01% | 356 |
|
|
2019
Q1 | $15K | Sell |
200
-51
| -20% | -$4.17K | ﹤0.01% | 555 |
|
|
2018
Q4 | $23K | Sell |
251
-118
| -32% | -$10.4K | ﹤0.01% | 521 |
|
|
2018
Q3 | $35K | Sell |
369
-181
| -33% | -$17.2K | ﹤0.01% | 556 |
|
|
2018
Q2 | $52K | Sell |
550
-10,184
| -95% | -$995K | ﹤0.01% | 513 |
|
|
2018
Q1 | $986K | Buy |
10,734
+1,988
| +23% | +$218K | ﹤0.01% | 438 |
|
|
2017
Q4 | $817K | Sell |
8,746
-4,022
| -32% | -$379K | ﹤0.01% | 447 |
|
|
2017
Q3 | $1.1M | Buy |
12,768
+5,558
| +77% | +$423K | ﹤0.01% | 416 |
|
|
2017
Q2 | $523K | Sell |
7,210
-6,483
| -47% | -$436K | ﹤0.01% | 471 |
|
|
2017
Q1 | $893K | Sell |
13,693
-2,001,651
| -99% | -$126M | ﹤0.01% | 470 |
|
|
2016
Q4 | $78.8M | Buy |
2,015,344
+1,964,656
| +3,876% | +$120M | 0.13% | 162 |
|
|
2016
Q3 | $3.2M | Buy |
50,688
+33,552
| +196% | +$2.17M | 0.01% | 350 |
|
|
2016
Q2 | $1.06M | Sell |
17,136
-326,294
| -95% | -$19.9M | ﹤0.01% | 408 |
|
|
2016
Q1 | $32.2M | Buy |
343,430
+300,831
| +706% | +$16.8M | 0.08% | 192 |
|
|
2015
Q4 | $2.54M | Sell |
42,599
-160,780
| -79% | -$9.26M | 0.01% | 337 |
|
|
2015
Q3 | $11.1M | Sell |
203,379
-508,860
| -71% | -$33.1M | 0.05% | 225 |
|
|
2015
Q2 | $47.8M | Buy |
712,239
+164,842
| +30% | +$10.8M | 0.16% | 137 |
|
|
2015
Q1 | $32.1M | Sell |
547,397
-211,923
| -28% | -$12.8M | 0.12% | 147 |
|
|
2014
Q4 | $49.5M | Buy |
759,320
+32,706
| +5% | +$2.06M | 0.15% | 133 |
|
|
2014
Q3 | $41.9M | Sell |
726,614
-21,923
| -3% | -$1.22M | 0.14% | 152 |
|
|
2014
Q2 | $42.2M | Buy |
748,537
+124,155
| +20% | +$6.51M | 0.13% | 162 |
|
|
2014
Q1 | $31.8M | Buy |
624,382
+228,262
| +58% | +$11.5M | 0.11% | 174 |
|
|
2013
Q4 | $20.9M | Buy |
+396,120
| New | +$19.5M | 0.08% | 188 |
|
|
2013
Q3 | – | Sell |
-382,920
| Closed | -$15.8M | – | 372 |
|
|
2013
Q2 | $15.8M | Buy |
+382,920
| New | +$16.7M | 0.07% | 186 |
|
Other funds holding ABBV
VCM
VPM
1832 Asset Management's ABBV Position: Q1 2026 in Review
1832 Asset Management increased its AbbVie (ABBV) stake by 178% in Q1 2026, buying an estimated $40M and bringing the position to 281,600 shares worth $61.2M. The position accounts for 0.06% of the portfolio, ranked #208.
1832 Asset Management first reported a position in ABBV in Q2 2013 and has held it in 51 quarters since. The position peaked at $148M in Q1 2024. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- 1832 Asset Management held 281,600 shares of AbbVie worth $61.2M as of Q1 2026.
- 1832 Asset Management bought 180,480 AbbVie shares in Q1 2026, an estimated $40M.
- AbbVie made up 0.06% of 1832 Asset Management's portfolio in Q1 2026, its #208 holding.
- 1832 Asset Management first reported a position in AbbVie in Q2 2013 and has held it in 51 quarters since.
- 1832 Asset Management's AbbVie position peaked at $148M in Q1 2024.
- 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on 1832 Asset Management's 13F filing for Q1 2026, filed 14 May 2026.